Collagen-binding human epidermal growth factor promotes cellularization of collagen scaffolds

Tissue Engineering - Part A

Volumn 15, Issue 11, 2009, Pages 3589-3596

  Yang, Yifan ^a,b   Zhao, Yannan ^a,b   Chen, Bing ^a   Han, Qianqian ^a   Sun, Wenjie ^a   Xiao, Zhifeng ^a   Dai, Jianwu ^a  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BIOLOGICAL MATERIALS; CELL CULTURE; LEAKAGE (FLUID); PEPTIDES; SCAFFOLDS;

BINDING ASSAYS; CLINICAL APPLICATION; COLLAGEN BINDING DOMAIN; COLLAGEN MEMBRANE; COLLAGEN SCAFFOLDS; EPIDERMAL GROWTH FACTORS; EXTRACELLULAR FLUID; FUSION PROTEINS; HUMAN EPIDERMAL GROWTH FACTOR; HUMAN FIBROBLAST; IN-VITRO BIOACTIVITY; IN-VIVO EXPERIMENTS; SPECIFIC BINDING; TISSUE REGENERATION;

COLLAGEN;

COLLAGEN; COLLAGEN BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; HYBRID PROTEIN; TISSUE SCAFFOLD;

ANIMAL EXPERIMENT; ARTICLE; BINDING ASSAY; BIOASSAY; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR FLUID; FIBROBLAST; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN RENATURATION; RAT; TISSUE REGENERATION;

EID: 72649101231     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0648     Document Type: Article

References (31)

1. Cohen, S. Nobel lecture. Epidermal growth factor. Biosci Rep 6, 1017, 1986.
2. Pastore, S., Mascia, F., Mariani, V., and Girolomoni, G. The epidermal growth factor receptor system in skin repair and inflammation. J Investig Dermatol 128, 1365, 2008.
3. Tripathi, R.C., Raja, S.C., and Tripathi, B.J. Prospects for epidermal growth factor in the management of corneal disorders. Surv Ophthalmol 34, 457, 1990.
4. Hall, F.L., Kaiser, A., Liu, L., Chen, Z.H., Hu, J., Nimni, M.E., Beart, R.W., Jr., and Gordon, E.M. Design, expression, and renaturation of a lesion-targeted recombinant epidermal growth factor-von Willebrand factor fusion protein: efficacy in an animal model of experimental colitis. Int J Mol Med 6, 635, 2000.
5. Kumar, R.K., Maronese, S.E., and Hassim, Z. Cooperative interaction of autocrine and paracrine mitogens for airway epithelial cells. Cell Biol Toxicol 14, 293, 1998.
6. Hardwicke, J., Schmaljohann, D., Boyce, D., and Thomas, D. Epidermal growth factor therapy and wound healing-past, present and future perspectives. Surgeon 6, 172, 2008.
7. Frew, S.E., Rezaie, R., Sammut, S.M., Ray, M., Daar, A.S., and Singer, P.A. India's health biotech sector at a crossroads. Nat Biotechnol 25, 403, 2007.
8. Mola, E.L., Acevedo, B.E., Silva, R., Tormo, B., Montero, R., and Herrera, L. Development of Cuban biotechnology. J Commer Biotechnol 9, 147, 2003.
9. Mast, B.A., and Schultz, G.S. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen 4, 411, 1996.
10. Buckley, A., Davidson, J.M., Kamerath, C.D., Wolt, T.B., and Woodward, S.C. Sustained release of epidermal growth factor accelerates wound repair. Proc Natl Acad Sci USA 82, 7340, 1985.
11. Schultz, G., Rotatori, D.S., and Clark, W. EGF and TGF-alpha in wound healing and repair. J Cell Biochem 45, 346, 1991.
12. Tanaka, A., Nagate, T., and Matsuda, H. Acceleration of wound healing by gelatin film dressings with epidermal growth factor. J Vet Med Sci 67, 909, 2005.
13. Lee, C.H., Singla, A., and Lee, Y. Biomedical applications of collagen. Int J Pharm 221, 1, 2001.
14. Supp, D.M., and Boyce, S.T. Engineered skin substitutes: practices and potentials. Clin Dermatol 23, 403, 2005.
15. Nishi, N., Matsushita, O., Yuube, K., Miyanaka, H., Okabe, A., and Wada, F. Collagen-binding growth factors: production and characterization of functional fusion proteins having a collagen-binding domain. Proc Natl Acad Sci USA 95, 7018, 1998.
16. de Souza, S.J., and Brentani, R. Collagen binding site in collagenase can be determined using the concept of sense-antisense peptide interactions. J Biol Chem 267, 13763, 1992.
17. Chen, B., Lin, H., Zhao, Y., Wang, B., Liu, Y., Liu, Z., and Dai, J. Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. J Biomed Mater Res A 80, 428, 2007.
18. Lin, H., Chen, B., Sun, W., Zhao, W., Zhao, Y., and Dai, J. The effect of collagen-targeting platelet-derived growth factor on cellularization and vascularization of collagen scaffolds. Biomaterials 27, 5708, 2006.
19. Ferrer Soler, L., Cedano, J., Querol, E., and de Llorens, R. Cloning, expression and purification of human epidermal growth factor using different expression systems. J Chro-matogr B Anal Technol Biomed Life Sci 788, 113, 2003.
20. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248, 1976.
21. Schagger, H., and von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166, 368, 1987.
22. Lembach, K.J. Induction of human fibroblast proliferation by epidermal growth factor (EGF): enhancement by an EGF-binding arginine esterase and by ascorbate. Proc Natl Acad Sci USA 73, 183, 1976.
23. Finnis, M.L., and Gibson, M.A. Microfibril-associated gly-coprotein-1 (MAGP-1) binds to the pepsin-resistant domain of the alpha3(VI) chain of type VI collagen. J Biol Chem 272, 22817, 1997.
24. Nimni, M.E. The molecular organization of collagen and its role in determining the biophysical properties of the connective tissues. Biorheology 17, 51, 1980.
25. Matsushita, O., Jung, C.M., Minami, J., Katayama, S., Nishi, N., and Okabe, A. A study of the collagen-binding domain of a 116-kDa Clostridium histolyticum collagenase. J Biol Chem 273, 3643, 1998.
26. Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., and Yokoyama, S. Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110, 775, 2002.
27. Playford, R.J., Marchbank, T., Calnan, D.P., Calam, J., Roy-ston, P., Batten, J.J., and Hansen, H.F. Epidermal growth factor is digested to smaller, less active forms in acidic gastric juice. Gastroenterology 108, 92, 1995.
28. Ishikawa, T., Terai, H., and Kitajima, T. Production of a biologically active epidermal growth factor fusion protein with high collagen affinity. J Biochem 129, 627, 2001.
29. Ishikawa, T., Terai, H., Yamamoto, T., Harada, K., and Kitajima, T. Delivery of a growth factor fusion protein having collagen-binding activity to wound tissues. Artif Organs 27, 147, 2003.
30. Lee, J.H., Ahn, S.H., Lee, E.M., Jeong, S.H., Kim, Y.O., Lee, S.J., and Kong, I.S. The FAXWXXT motif in the carboxyl terminus of Vibrio mimicus metalloprotease is involved in binding to collagen. FEBS Lett 579, 2507, 2005.
31. Kim, D.G., Min, M.K., Ahn, S.C., Kim, J.K., and Kong, I.S. Expression of a fusion protein containing human epidermal growth factor and the collagen-binding domain of Vibrio mimicus metalloprotease. Biotechnol Lett 31, 259, 2009